Citations in PubMed

Primary Citation PubMed: 20098425 Citations in PubMed

PDB ID Mentions in PubMed Central Article count: 3

Citations in PubMed

This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.

PDB ID Mentions in PubMed Central

Data mentions are occurrences of PDB IDs in the full text articles from the PubMedCentral Open Access Subset of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed. Article titles can be filtered by keywords and sorted by year.

  • 3 per page
  • 5 per page
  • 10 per page
  • view all
  • Publication Year
  • Ascending
  • Descending

Proof of principle for epitope-focused vaccine design.

(2014) Nature 507

PubMed: 24499818 | PubMedCentral: PMC4260937 | DOI: 10.1038/nature12966

g , Superposition of the epitope structure from unliganded FFL_005 (yellow) and the complex of peptide (green) bound to Mota from PDBid:3ixt.

h , Superposition of the Mota-liganded structures of FFL_001 and peptide (PDBid:3ixt).

c , MR model of 31-HG7 bound to FFL_001 (left), a crystal structure of 17-HD9 bound to a 35-residue helix-turn-helix peptide from FFL_001 (middle), and the crystal structure (PDB: 3ixt) of Mota bound to peptide.

Design of Epitope-Scaffolds To design scaffolds for the helix-turn-helix conformation of the Mota epitope (PDBid: 3IXT, chain P), we selected a three-helix bundle (PDBid: 3LHP, chain S) as the template topology.

Compared to the structure of peptide in complex with Mota (PDBid: 3IXT), the epitope backbone RMSDs were 0.5 Å for FFL_005 ( Fig. 2g ) and 0.4 Å for FFL_001.

Publication Year: 2014

PubMed ID is not available.

Published in 2015

PubMedCentral: PMC4441423

Epitopes captured to date were also defined by crystallographic analysis of antigen-antibody complexes (x-ray crystallography) [PDBs: 3IXT, 3QWO, 4JLR (motavizumab), 4JHW (D25), 4N9G (17HD9), 3O41, 3O... 5 (101F)].

Publication Year: 2015

PubMed ID is not available.

Published in 2015

PubMedCentral: PMC4498696

A molecular replacement solution for the 5.5 Å ternary complex was obtained using PHASER with prefusion RSV F (PDB ID: 4JHW [ 19 ]), motavizumab Fab (PDB ID: 3IXT [ 11 ]) and the 2.0 Å... AM14 Fab structures as search models.

The reference models were the 2.4 Å prefusion F structure (PDB ID: 4MMS [ 26 ]), the 2.75 Å motavizumab Fab structure (PDB ID: 3IXT [ 11 ]), and the 2.0 Å AM14 Fab structure determined here.

Publication Year: 2015